Nick Wilson

Person

Brighton East, AU

People

Patents Grantslast 30 patents

Information Patent Grant
CD131 binding proteins and uses thereof
- Patent number 11,840,573
- Issue date Dec 12, 2023
- CSL LIMITED
- Catherine Owczarek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD131 binding proteins
- Patent number 10,894,834
- Issue date Jan 19, 2021
- CSL Limited
- Catherine Owczarek
- G01 - MEASURING TESTING
Information Patent Grant
Compositions and methods for targeting type 1 interferon producing...
- Patent number 9,758,585
- Issue date Sep 12, 2017
- CSL Limited
- Gino Luigi Vairo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating lupus by administering humanized anti-interleuk...
- Patent number 8,535,669
- Issue date Sep 17, 2013
- CSL Limited
- Gino Luigi Vairo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD131 BINDING PROTEINS AND USES THEREOF
- Publication number 20240174757
- Publication date May 30, 2024
- CSL LIMITED
- Catherine OWCZAREK
- G01 - MEASURING TESTING
Information Patent Application
CD131 BINDING PROTEINS AND USES THEREOF
- Publication number 20210324091
- Publication date Oct 21, 2021
- CSL Limited
- Catherine OWCZAREK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING ASTHMA
- Publication number 20210009677
- Publication date Jan 14, 2021
- CSL Limited
- Nicholas WILSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF
- Publication number 20190185573
- Publication date Jun 20, 2019
- CSL Limited
- Nicholas WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD131 BINDING PROTEINS AND USES THEREOF
- Publication number 20190062438
- Publication date Feb 28, 2019
- CSL Limited
- Catherine OWCZAREK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI IL-3R ALPHA AGENTS AND USES THEREOF
- Publication number 20180244786
- Publication date Aug 30, 2018
- CSL Limited
- Angel Francisco LOPEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF
- Publication number 20180208661
- Publication date Jul 26, 2018
- CSL Limited
- Nicholas WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF
- Publication number 20160046718
- Publication date Feb 18, 2016
- CSL Limited
- Nicholas WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI IL-3R ALPHA AGENTS AND USES THEREOF
- Publication number 20160031996
- Publication date Feb 4, 2016
- CSL Limited
- Angel Francisco LOPEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING...
- Publication number 20150147322
- Publication date May 28, 2015
- CSL Limited
- Gino Luigi VAIRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING...
- Publication number 20140178364
- Publication date Jun 26, 2014
- CSL Limited
- Gino Luigi Vairo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING...
- Publication number 20130084282
- Publication date Apr 4, 2013
- CSL Limited
- Gino Luigi Vairo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Nick Wilson

Person

Patents Grantslast 30 patents

CD131 binding proteins and uses thereof

CD131 binding proteins

Compositions and methods for targeting type 1 interferon producing...

Methods of treating lupus by administering humanized anti-interleuk...

Patents Applicationslast 30 patents

CD131 BINDING PROTEINS AND USES THEREOF

CD131 BINDING PROTEINS AND USES THEREOF

METHOD OF TREATING ASTHMA

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

CD131 BINDING PROTEINS AND USES THEREOF

ANTI IL-3R ALPHA AGENTS AND USES THEREOF

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

ANTI IL-3R ALPHA AGENTS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING...

COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING...

COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING...